NCT04232566View on ClinicalTrials.gov

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 20, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Obesity, MorbidNASH - Nonalcoholic SteatohepatitisChronic Inflammation
Interventions
PROCEDURE

Bariatric surgery

Evaluate liver fibrosis by elastography before gastric bypass surgery.

Trial Locations (1)

85259

RECRUITING

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04232566 - Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity | Biotech Hunter | Biotech Hunter